![](https://endpts.com/wp-content/uploads/2022/11/Eric-Murphy-Alterome-tile1.jpg)
Eric Murphy, Alterome CEO
Alterome raises $132M to take next-gen cancer drugs aimed at the 'undruggable' into clinic
With a new $132 million in hand, Alterome Therapeutics is finally divulging what it’s working on.
The oncology company will be using its Series B …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.